Serial 75282080
Live / Registered — Registered and renewed (as of 21 May 2018)
What this means for you
Registered since 19 May 1998. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2018).
Record
- Serial number
- 75282080
- Registration number
- 2158841
- Mark type
- Design / logo
- Filed
- 28 Apr 1997
- Published for opposition
- 24 Feb 1998
- Registered
- 19 May 1998
- Next maintenance due
- 19 May 2018
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical tablet in the nature of medication for the treatment of hypothyroidism in humans
Owner
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC, New York, NY, US
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., Cary, NC, US
- Jones Pharma Incorporated, Bristol, VA, US
- JMI-Daniels Pharmaceuticals, Inc., St. Louis, MO, US
- JMI-Daniels Pharmaceuticals, Inc., St. Louis, MO, US
- JMI-Daniels Pharmaceuticals, Inc., St. Louis, MO, US
Prosecution history
- 29 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 May 2018 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 21 May 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 May 2018 — TEAS SECTION 8 & 9 RECEIVED
- 27 Dec 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP